1. . 2014. Comprehensive molecular characterization of gastric adenocarcinoma. In Nature, 513, 202-9. doi:10.1038/nature13480. https://pubmed.ncbi.nlm.nih.gov/25079317/
2. Maier, Barbara, Leader, Andrew M, Chen, Steven T, Brown, Brian D, Merad, Miriam. 2020. A conserved dendritic-cell regulatory program limits antitumour immunity. In Nature, 580, 257-262. doi:10.1038/s41586-020-2134-y. https://pubmed.ncbi.nlm.nih.gov/32269339/
3. . 2017. Integrated genomic and molecular characterization of cervical cancer. In Nature, 543, 378-384. doi:10.1038/nature21386. https://pubmed.ncbi.nlm.nih.gov/28112728/
4. Li, Bin, Ren, Mei-Yu, Chen, Yu-Zhen, Su, Zhi-Peng, Yang, Bo. 2022. SYNGR2 serves as a prognostic biomarker and correlates with immune infiltrates in esophageal squamous cell carcinoma. In The journal of gene medicine, 24, e3441. doi:10.1002/jgm.3441. https://pubmed.ncbi.nlm.nih.gov/35840542/
5. Masugi, Yohei, Nishihara, Reiko, Hamada, Tsuyoshi, Nowak, Jonathan A, Ogino, Shuji. 2017. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. In Cancer immunology research, 5, 1046-1055. doi:10.1158/2326-6066.CIR-17-0122. https://pubmed.ncbi.nlm.nih.gov/29038297/
6. Pozdeyev, Nikita, Gay, Laurie M, Sokol, Ethan S, Haugen, Bryan R, Bowles, Daniel W. 2018. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers. In Clinical cancer research : an official journal of the American Association for Cancer Research, 24, 3059-3068. doi:10.1158/1078-0432.CCR-18-0373. https://pubmed.ncbi.nlm.nih.gov/29615459/
7. Wan, Siyuan, Liu, Lixiang, Ren, Bingxuan, Wang, Xiaoming, Shen, Hongmei. 2021. DNA Methylation Patterns in the HLA-DPB1 and PDCD1LG2 Gene Regions in Patients with Autoimmune Thyroiditis from Different Water Iodine Areas. In Thyroid : official journal of the American Thyroid Association, 31, 1741-1748. doi:10.1089/thy.2021.0221. https://pubmed.ncbi.nlm.nih.gov/34382413/
8. Rotman, Jossie, den Otter, Leontine A S, Bleeker, Maaike C G, de Gruijl, Tanja D, Jordanova, Ekaterina S. 2020. PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential. In Frontiers in immunology, 11, 596825. doi:10.3389/fimmu.2020.596825. https://pubmed.ncbi.nlm.nih.gov/33424844/
智鼠故事 
